Cresco Labs Inc. Share Price OTC Markets

Equities

CRLBF

CA22587M1068

Pharmaceuticals

Market Closed - OTC Markets 21:00:01 17/05/2024 BST 5-day change 1st Jan Change
2.16 USD -2.70% Intraday chart for Cresco Labs Inc. +2.86% +59.32%
Sales 2024 * 745M 58.67B Sales 2025 * 794M 62.54B Capitalization 763M 60.1B
Net income 2024 * -28M -2.2B Net income 2025 * -27M -2.13B EV / Sales 2024 * 1.68 x
Net Debt 2024 * 486M 38.26B Net Debt 2025 * 458M 36.08B EV / Sales 2025 * 1.54 x
P/E ratio 2024 *
-33.8 x
P/E ratio 2025 *
-39.5 x
Employees 2,760
Yield 2024 *
-
Yield 2025 *
-
Free-Float 73.68%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.70%
1 week+2.86%
Current month-12.90%
1 month-1.37%
3 months+24.66%
6 months+21.35%
Current year+59.32%
More quotes
1 week
2.00
Extreme 2
2.35
1 month
1.92
Extreme 1.915
2.60
Current year
1.33
Extreme 1.33
2.65
1 year
1.00
Extreme 1
2.77
3 years
1.00
Extreme 1
12.88
5 years
1.00
Extreme 1
17.49
10 years
1.00
Extreme 1
17.49
More quotes
Managers TitleAgeSince
Founder 45 31/01/15
President 44 -
Director of Finance/CFO 61 30/06/20
Members of the board TitleAgeSince
Director/Board Member 76 28/02/17
Director/Board Member 67 -
Chairman 68 31/12/12
More insiders
Date Price Change Volume
17/05/24 2.16 -2.70% 839,702
16/05/24 2.22 +6.22% 1,814,395
15/05/24 2.09 +3.47% 3,571,874
14/05/24 2.02 +0.50% 803,371
13/05/24 2.01 -4.29% 539,230

Delayed Quote OTC Markets, May 17, 2024 at 09:00 pm

More quotes
Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s. Its portfolio consists of over 400 products. The Company's products are sold in over 1,600 dispensaries across the country. Its Cresco offers consistent strains, available in a variety of product forms at dispensaries and retail locations nationwide. Its High Supply lab-tested; and available in vape carts, vape pens, flower, popcorn, shake, shorties and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Its Mindy’s offers dosed edibles created by James Beard. It is the wholesaler of branded cannabis products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2.183 USD
Average target price
4.41 USD
Spread / Average Target
+102.01%
Consensus